Stocks and Investing Stocks and Investing
Thu, August 11, 2022
Wed, August 10, 2022

Andrew Fein Maintained (ZNTL) at Strong Buy with Decreased Target to $55 on, Aug 10th, 2022


Published on 2024-10-27 22:35:41 - WOPRAI, Andrew Fein
  Print publication without navigation


Andrew Fein of HC Wainwright & Co., Maintained "Zentalis Pharmaceuticals, Inc." (ZNTL) at Strong Buy with Decreased Target from $120 to $55 on, Aug 10th, 2022.

Andrew has made no other calls on ZNTL in the last 4 months.



There are 3 other peers that have a rating on ZNTL. Out of the 3 peers that are also analyzing ZNTL, 0 agree with Andrew's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Andrew


  • Bradley Canino of "Stifel" Maintained at Strong Buy with Decreased Target to $70 on, Friday, July 29th, 2022
  • Tyler Van Buren of "Cowen & Co." Initiated at Buy on, Tuesday, July 12th, 2022
  • Matthew Biegler of "Oppenheimer" Maintained at Buy with Decreased Target to $85 on, Tuesday, April 12th, 2022
Contributing Sources